These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12759624)

  • 1. Low-dose tissue plasminogen activator thrombolysis in children.
    Wang M; Hays T; Balasa V; Bagatell R; Gruppo R; Grabowski EF; Valentino LA; Tsao-Wu G; Manco-Johnson MJ;
    J Pediatr Hematol Oncol; 2003 May; 25(5):379-86. PubMed ID: 12759624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
    Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
    J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis.
    El-Segaier M; Khan MA; Khan ZU; Momenah T; Galal MO
    Pediatr Cardiol; 2015 Dec; 36(8):1582-7. PubMed ID: 25991571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience.
    Bratincsák A; Moore JW; El-Said HG
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):782-5. PubMed ID: 22718305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis with recombinant tissue plasminogen activator in 7 children.
    Evim MS; Bostan Ö; Baytan B; Semizel E; Günes AM
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):574-7. PubMed ID: 22496087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue Plasminogen Activator Use in Pediatric Patients: A Single Center Experience.
    Pekpak E; İnce E; Ertem M; Tutar E; İleri T; Ucar T; Tiras ST; Cakmakli HF; Uysal Z
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e648-e651. PubMed ID: 33480646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
    Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
    Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic therapy using a low dose of tissue plasminogen activator in children].
    Santiago MJ; López-Herce J; Zarzoso S; Sánchez A; Mencía S; Carrillo A
    An Pediatr (Barc); 2012 Feb; 76(2):77-82. PubMed ID: 21982548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns].
    Álvarez Z P; Verdugo L P; Carvajal K L; Múhlhausen M G; Ríos A P; Rodríguez V D
    Rev Chil Pediatr; 2015; 86(3):194-9. PubMed ID: 26235268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
    Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
    J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis in newborns and infants.
    Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
    Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis of venous and arterial thrombosis by catheter-directed low-dose infusion of tissue plasminogen activator in children.
    Cannizzaro V; Berger F; Kretschmar O; Saurenmann R; Knirsch W; Albisetti M
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):688-91. PubMed ID: 16344680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
    Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
    Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with recombinant tissue plasminogen activator in the management of intracardiac and arterial thrombosis in children.
    Olgun H; Buyukavci M; Ceviz N; Sahin IO; Yildirim ZK; Colak A; Tekgunduz KS; Caner I
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):726-30. PubMed ID: 24806322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis.
    Grunwald MR; Hofmann LV
    J Vasc Interv Radiol; 2004 Apr; 15(4):347-52. PubMed ID: 15064337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.
    Viegas LD; Stolz E; Canhão P; Ferro JM
    Cerebrovasc Dis; 2014; 37(1):43-50. PubMed ID: 24356180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-Directed Low-Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter.
    Orgeron GM; Pollard JL; Pourmalek P; Sloane PJ
    Pharmacotherapy; 2015 Oct; 35(10):e153-8. PubMed ID: 26497485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
    Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
    J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.